The Enterprise Value as of June 2026 (TTM) for Predictive Oncology Inc. (POAI) is 18.63M

According to Predictive Oncology Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 18.63M. This represents a change of -72.53% compared to the average of 67.84M of the last 4 quarters.

Predictive Oncology Inc. (POAI) Historical Enterprise Value (quarterly & annually)

How has POAI Enterprise Value performed in the past?

The mean historical Enterprise Value of Predictive Oncology Inc. over the last ten years is 202.92M. The current 18.63M Enterprise Value has changed 818.35% with respect to the historical average. Over the past ten years (40 quarters), POAI's Enterprise Value was at its highest in in the September 2021 quarter at 1.26B. The Enterprise Value was at its lowest in in the September 2025 quarter at 12.01M.

Predictive Oncology Inc. (POAI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Predictive Oncology Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Predictive Oncology Inc. (POAI) Average Enterprise Value

How has POAI Enterprise Value performed in the past?

The current Enterprise Value of Predictive Oncology Inc. (POAI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Predictive Oncology Inc. (POAI) Enterprise Value vs. Peers

How is POAI’s Enterprise Value compared to its peers?

Predictive Oncology Inc.’s Enterprise Value is greater than Mainz Biomed B.V. (17.33M), greater than Bionano Genomics, Inc. (7.13M), greater than VYNE Therapeutics Inc. (-13823812.00), greater than Pasithea Therapeutics Corp. (-46001320.00), greater than GBS Inc. (-3463978.00), greater than Alaunos Therapeutics, Inc. (5.17M), greater than HeartSciences Inc. (-3389266819.00), greater than Cyclerion Therapeutics, Inc. (11.25M), greater than AIM ImmunoTech Inc. (139.50K), greater than Autonomix Medical, Inc. Common Stock (-5019627.00),

Build a custom stock screener for Predictive Oncology Inc. (POAI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Predictive Oncology Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Predictive Oncology Inc. (POAI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Predictive Oncology Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.